Laszlo Markasz

Laszlo Markasz

Auto-generated profile, based on publicly available information

Laszlo Markasz

Department of Women’s and Children’s Health, Uppsala University, Uppsala, Sweden

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2010 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
EFEmilie Flaberg
Emilie Flaberg
LMLaszlo Markasz
Laszlo Markasz
GPGabor Petranyi
Gabor Petranyi
GSGyorgy Stuber
Gyorgy Stuber
FDFerenc Dicső
Ferenc Dicső
LSLászló Székely
László Székely
Increasing evidence indicates that cancer development requires changes both in the precancerous cells and in their microenvironment. To study one aspect of the microenvironmental control, we departed from Michael Stoker's observation (Stroker et al, J Cell Sci 1966;1:297–310) that normal fibroblasts can inhibit the growth of admixed cancer cells (neighbour suppression). We have developed a high‐throughput microscopy and image analysis system permitting the examination of live mixed cell cultures growing on 384‐well plates, at the single cell level and over time. We have tested the effect of 107 samples of low passage number (<5) primary human fibroblasts from pediatric and adult donors, on the growth of six human tumor cell lines. Three of the lines were derived from prostate carcinomas, two from lung carcinomas and one was an EBV‐transformed lymphoblastoid line. Labeled tumor cells were grown in the presence of unlabeled fibroblasts. The majority of the tested fibroblasts inhibited the proliferation of the tumor cells, compared to the control cultures where labeled tumor cells were co‐cultured with unlabeled tumor cells. The proliferation inhibiting effect of the fibroblasts differed depending on their site of origin and the age of the donor. Inhibition required direct cell contact. Mouse 3T3 fibroblasts inhibited the growth of SV40‐transformed 3T3 cells and human tumor cells, showing that the inhibitory effect could prevail across the species barrier. Our high‐throughput system allows the quantitative analysis of the inhibitory effect of fibroblasts on the population level and the exploration of differences depending on the source of the normal cells.

1 February 2007 in Molecular Cancer Therapeutics
Verified
Journal Article
Open access
PDF file
LMLaszlo Markasz
Laszlo Markasz
GSGyorgy Stuber
Gyorgy Stuber
BVBruno Vanherberghen
Bruno Vanherberghen
EFEmilie Flaberg
Emilie Flaberg
EOEva Olah
Eva Olah
LSLászló Székely
László Székely
Tumors are considered to be possible targets of immunotherapy using stimulated and expanded autologous or allogeneic natural killer (NK) cells mismatched for MHC class I molecules and inhibitory NK receptors. NK cell–based immunoadjuvant therapies are carried out in combination with standard chemotherapeutic protocols. In the presented study, we characterized the effect of 28 frequently used chemotherapeutic agents on the capacity of NK cells to kill target cells. We found that treatment of NK cells with the drugs vinblastine, paclitaxel, docetaxel, cladribine, chlorambucil, bortezomib, and MG-132 effectively inhibited NK cell–mediated killing without affecting the viability of NK cells. On the other hand, the following drugs permitted efficient NK cell–mediated killing even at concentrations comparable with or higher than the maximally achieved therapeutic concentration in vivo in humans: asparaginase, bevacizumab, bleomycin, doxorubicin, epirubicin, etoposide, 5-fluorouracil, hydroxyurea, streptozocin, and 6-mercaptopurine. [Mol Cancer Ther 2007;6(2):644–54]

8 August 2008 in Cellular Signalling
Verified
Journal Article
Closed access
AKAndrea Kiss
Andrea Kiss
BLBeáta Lontay
Beáta Lontay
BBBálint Bécsi
Bálint Bécsi
LMLászló Márkász
László Márkász
ÉOÉva Oláh
Éva Oláh
FEFerenc Erdődi
Ferenc Erdődi

1 April 2008 in Journal of Immunotherapy
Verified
Journal Article
Closed access
LMLaszlo Markasz
Laszlo Markasz
HSHenriette Skribek
Henriette Skribek
MUMichael Uhlin
Michael Uhlin
RORita Otvos
Rita Otvos
EFEmilie Flaberg
Emilie Flaberg
LSLászló Székely
László Székely
Tumors are considered to be possible targets of immunotherapy using stimulated and expanded cytotoxic T-lymphocytes (CTL). It is important to consider the drug-induced effects when chemotherapeutic regimens and CTL-mediated immunotherapy is planned to be used in parallel. In this study, we characterized the effect of 29 frequently used chemotherapeutic agents on the cytotoxic activity of autologous and allogeneic CTLs. We found that treatment of CTLs with the following drugs: docetaxel, vincristine, chlorambucil, mitomycin C, oxaliplatin, doxorubicin, and bleomycin effectively inhibited CTL-mediated killing, without affecting their viability. On the other hand, the following drugs enhanced or permitted efficient CTL-mediated killing in vitro at concentrations comparable with the maximally achieved therapeutic concentration in vivo in humans: daunorubicin, prednisolone, vinorelbine, cisplatin, methotrexate, hydroxyurea, cytarabine, cyclophosphamide, topotecan, epirubicin, fluorouracil, carboplatin, asparaginase, 6-mercaptopurine, and bortezomib. Our results could potentially be used in the future to design new CTL-based adjuvant immunotherapy protocols.

13 April 2007 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
GSGyörgy Stuber
György Stuber
KMKarin Mattsson
Karin Mattsson
EFEmilie Flaberg
Emilie Flaberg
EKEmrah Kati
Emrah Kati
LMLaszlo Markasz
Laszlo Markasz
LSLászló Székely
László Székely
The latency-associated nuclear antigen (LANA-1) of Human Herpes Virus 8 (HHV-8), alternatively called Kaposi Sarcoma Herpes Virus (KSHV) is constitutively expressed in all HHV-8 infected cells. LANA-1 accumulates in well-defined foci that co-localize with the viral episomes. We have previously shown that these foci are tightly associated with the borders of heterochromatin [1]. We have also shown that exogenously expressed LANA-1 causes an extensive re-organization of Hoechst 33248 DNA staining patterns of the nuclei in non-HHV-8 infected cells [2]. Here we show that this effect includes the release of the bulk of DNA from heterochromatic areas, in both human and mouse cells, without affecting the overall levels of heterochromatin associated histone H3 lysine 9 tri-methylation (3MK9H3). The release of DNA from the heterochromatic chromocenters in LANA-1 transfected mouse cells co-incides with the dispersion of the chromocenter associated methylcytosin binding protein 2 (MECP2). The localization of 3MK9H3 to the remnants of the chromocenters remains unaltered. Moreover, exogeneously expressed LANA-1 leads to the relocation of the chromocenters to the nuclear periphery, indicating extensive changes in the positioning of the chromosomal domains in the LANA-1 harboring interphase nucleus. Using a series of deletion mutants we have shown that the chromatin rearranging effects of LANA-1 require the presence of a short (57 amino acid) region that is located immediately upstream of the internal acidic repeats. This sequence lies within the previously mapped binding site to histone methyltransferase SUV39H1. We suggest that the highly concentrated LANA-1, anchored to the host genome in the nuclear foci of latently infected cells and replicated through each cell generation, may function as "epigenetic modifier". The induction of histone modification in adjacent host genes may lead to altered gene expression, thereby contributing to the viral oncogenesis.

1 February 2015 in Cellular Signalling
Verified
Journal Article
Closed access
DDDóra Dedinszki
Dóra Dedinszki
AKAndrea Kiss
Andrea Kiss
LMLászló Márkász
László Márkász
AMAdrienn Márton
Adrienn Márton
Emese TóthEmese Tóth
Emese Tóth
FEFerenc Erdodi
Ferenc Erdodi